Welcome to our dedicated page for Maris Tech Ltd. SEC filings (Ticker: MTEK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Maris-Tech Ltd. filings document its foreign private issuer reporting and material-event disclosures for an AI edge video business serving defense and security applications. Recent Form 6-K reports furnish press releases on customer orders, pilot programs, product capabilities, trade-event participation and commercial activity tied to the company's video processing, onboard intelligence and situational-awareness systems.
The filings also provide formal disclosure categories for material agreements, shareholder voting matters, capital-structure items, operating and financial results, and other corporate updates. For this issuer, those records connect regulatory reporting to the development and commercialization of compact video, AI and sensor products such as Jupiter, Diamond Ultra and Peridot.
Maris-Tech Ltd. reported that it has received an order to conduct a situational awareness pilot program on an armored vehicle platform in the United States. The pilot will integrate the Diamond Ultra platform, the Peridot night-vision module, and a thermal camera dome to provide multi-directional sensing.
By fusing multiple electro-optical and thermal sensor inputs into a unified 3D operational view, the pilot is intended to demonstrate improved battlefield and environmental awareness for armored vehicle crews. If successful, the company believes this could support broader use of its solutions in the U.S. and global defense markets.
Maris-Tech Ltd. reported that it has received a follow-on order from an existing governmental customer operating in the intelligence domain. The new order reflects continued deployment and operational use of Maris-Tech’s video and AI-based edge computing solutions and underscores the customer’s confidence in the technology’s real-world performance.
The company positions its AI-powered edge video platforms for mission-critical defense and security operations, including intelligence gathering, surveillance, and real-time situational awareness in bandwidth- and latency-constrained environments. Maris-Tech notes that these systems are deployed across unmanned and manned platforms such as UAVs, UGVs, armored vehicles, and dismounted soldier systems.
Maris-Tech Ltd. reported a development milestone in its collaboration with Quantum Gyro Ltd. on quantum navigation technology for autonomous defense systems. Quantum Gyro entered an exclusive license agreement with its parent, Quantum X Labs Ltd., covering quantum gyroscope technology for navigation and GPS replacement uses.
Quantum X Labs is the assignee of U.S. Provisional Patent Application No. 64/000,184, filed on March 9, 2026, for an advanced nuclear magnetic resonance gyroscope. The partners are developing a hybrid navigation architecture that combines Maris-Tech’s edge AI processing with a quantum-based gyroscope to enable highly precise, resilient navigation for unmanned aerial and autonomous platforms in GPS-denied or contested environments.
Maris Tech Ltd. Chief Financial Officer Bussy Nir filed an initial Form 3 showing holdings of two share option grants over ordinary shares. One grant covers 1,990 underlying shares at an exercise price of $1.0000 expiring on March 31, 2027, and another covers 15,919 underlying shares at $1.0600 expiring on January 14, 2029. Footnotes explain these options were granted in April 2022 and January 2024 with 50% vesting after 24 months and the rest in eight equal quarterly installments.
Maris Tech Ltd. director Avrahamy Naama Falach filed an initial Form 3 reporting holdings of share options rather than recent stock trades. The filing shows options over 2,500 ordinary shares at an exercise price of $1.0000 expiring on February 3, 2027, and options over 5,000 ordinary shares at $1.0600 expiring on March 3, 2029.
Footnotes explain that the first grant, dated February 4, 2022, vests in sixteen equal quarterly installments of 6.25% beginning three months after the grant date. The second grant, dated March 4, 2024, vests with 50% after 24 months from a vesting start date of January 15, 2024, and the remaining 50% in eight equal quarterly installments of 6.25% each.
Maris Tech Ltd. director and Chief Executive Officer Bar Israel filed an initial statement of beneficial ownership. The filing shows direct ownership of 2,483,425 ordinary shares and share options to acquire 240,000 ordinary shares at an exercise price of $1.0000 per share, expiring on March 3, 2029. According to the vesting terms, 50% of these options vest twenty-four months after the vesting commencement date of January 15, 2024, with the remaining 50% vesting in eight equal quarterly installments of 6.25% each thereafter.
Maris Tech Ltd. director Marshak Isabela filed an initial statement of beneficial ownership, reporting two option grants over ordinary shares. She holds options to buy 2,500 shares at $1.0000 per share expiring on December 27, 2027, and options to buy 5,000 shares at $1.0600 per share expiring on March 3, 2029. Footnotes explain that each grant vests 50% after 24 months, with the remaining 50% vesting in eight equal quarterly installments.
Maris Tech Ltd. Chief Technology Officer Malka Hananya reported existing holdings of two share option awards over ordinary shares. Each option grant covers 31,838 underlying ordinary shares, with exercise prices of $1.00 and $1.06, expiring on February 3, 2027 and January 14, 2029, respectively.
The footnotes explain that the first grant was made on February 4, 2022 and the second on January 15, 2024. For both grants, 50% of the options vest 24 months after the grant date, and the remaining 50% vests in eight equal quarterly installments of 6.25% each.
Maris Tech Ltd. executive Carmela Bastiker, the Chief Operating Officer, filed an initial insider report showing existing stock option holdings. She holds options to buy 31,838 ordinary shares at an exercise price of 1.0000 per share, expiring on February 3, 2027, and options to buy another 31,838 ordinary shares at 1.0600 per share, expiring on January 14, 2029. The footnotes explain that the first grant was made on February 4, 2022 and the second on January 15, 2024, with each grant vesting 50% after 24 months and the remaining 50% in eight equal quarterly installments of 6.25% each.